Anti-interleukin-1 agents for pericarditis: a primer for cardiologistsState of the Art Review Published on 2022-08-142024-09-04 Journal: European Heart Journal [Category] 대상포진, [키워드] Anakinra interleukin-1 Pericarditis rilonacept [DOI] 10.1093/eurheartj/ehab452 PMC 바로가기 [Article Type] State of the Art Review
The efficacy of anakinra compared to standard care of treatment for COVID-19: a meta-analysisMeta-Analysis Published on 2022-06-012023-07-10 Journal: Turkish Journal of Medical Sciences [Category] COVID19(2023년), [키워드] Anakinra COVID-19 Cytokine storm Meta-analysis Mortality [DOI] 10.55730/1300-0144.5345 [Article Type] Meta-Analysis
Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysisCOVID-19 환자에서 염증성 바이오마커 감소에 대한 아나킨라 치료 효능: 메타 분석Meta-Analysis Published on 2022-06-012022-09-11 Journal: Journal of Clinical Laboratory Analysis [Category] COVID19(2023년), SARS, 바이오마커, [키워드] acute-phase reactant Admission Anakinra analyzed anti-inflammatory agent C-reactive protein C-reactive protein (CRP Care Cochrane Central concentrations conducted COVID-19 COVID-19 patients CRP CRP value CRP values D-dimer database dimer Efficacy elevated ferritin Follow-up hematological Inflammatory Inflammatory biomarker inflammatory biomarkers interleukin interleukin-1 Laboratory males Manger marker mean difference mean value Meta-analysis notable Patient Protein reduce mortality reduced reduction review SARS-CoV-2 serum Serum ferritin SMD statistically the mean Treatment treatment of COVID-19 patients trials Web of Science [DOI] 10.1002/jcla.24434 PMC 바로가기 [Article Type] Meta-Analysis
Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients기준선에서 가용성 IL-2R 수준은 COVID-19 환자에서 심각한 호흡 부전 및 사망의 발병을 예측합니다Article Published on 2022-04-102022-09-11 Journal: Viruses [Category] 바이오마커, [키워드] 95%CI Admission Algorithm Anakinra Biomarker change clinical outcomes coronavirus coronavirus disease Coronavirus disease-19 Corticosteroid Corticosteroids COVID-19 Critical cut-off Delta development died discharge disease severity Endpoint failure Follow-up hazard ratio Immunoglobulin Immunotherapy interquartile range Intravenous immunoglobulin Intubated intubation Laboratory Level Local local treatment marker median age moderate disease Mortality on admission Patient positive predict Predictive Predictive value receptor respiratory Respiratory failure risk Risk factors risk stratification severe disease severe respiratory failure significantly higher soluble interleukin-2 receptor SRF Stratification the strongest Tocilizumab Treatment were measured [DOI] 10.3390/v14040787 PMC 바로가기 [Article Type] Article
Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USAObservational Study Published on 2022-04-042022-10-05 Journal: Clinical and experimental immunology [Category] 임상, [키워드] Admission age Anakinra Analysis Antibiotics Clinical practice condition coronavirus disease Corticosteroids COVID-19 database database studies diagnosed diagnosed with COVID-19 died discharged Evidence finding hospital Hospital admission hyperinflammation ICU ICU admission intensive care interleukin (IL)-1 interleukin-1 receptor antagonist protein male mechanical ventilation Mortality Myocardial infarction Patient Real-world evidence receiving receptor renal required retrospective significantly higher significantly lower significantly shorter Standard deviation the mean treated Treatment USA [DOI] 10.1093/cei/uxab024 PMC 바로가기 [Article Type] Observational Study
Pharmacological treatment of COVID-19: an opinion paperCOVID-19의 약리학적 치료: 의견서Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 치료제, [키워드] adalimumab Anakinra approach AZD7442 Azithromycin Banlanivimab Baricitinib BRII-196 BRII-198 canakinumab Casirivimab Certolizumab Ciganilmab Colchicine college Committee convalescent convalescent plasma COVID-19 Critical Dexamethasone drug drugs effective Efficacy English Etanercept etesevimab Evusheld Favipiravir fluvoxamine Golimumab help Hydroxychloroquine Imdevinab immune response Immunotherapy indication infliximab itolizumab Ivermectin Lemilumab Lopinavir Lopinavir/ritonavir Medicines metformin molnupiravir offer Pandemia pandemic Paxlovid PF-07321332 physician precocity prevented Ravulizumab Remdesivir Ritonavir ruxolitinib sarilumab SARS-CoV-2 Scientific Committee Sotrovimab Spanish the vaccine therapeutic Tixagevimab Tocilizumab Tofacitinib Treatment Vaccine virus Vitamin Vitamin D [DOI] 10.37201/req/158.2021 PMC 바로가기 [Article Type] Review
Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination증례 보고서: ChAdOx1 nCoV-19 백신 접종 후 심각한 횡문근 융해증 및 다기관 부전Case Reports Published on 2022-03-172022-09-12 Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, [키워드] accelerated Anakinra assumption biologic Bone marrow Case report ChAdOx1 ChAdOx1 nCoV-19 characterized creatine phosphokinase cytokine Cytokine storm Deterioration dramatic increase drug eculizumab failure first dose had no healthy hypoglycemia immunosuppressive Infection inflammatory markers kidney liver lung multi organ failure nine occur occurred patient death patients with SARS-CoV-2 PCT physician procalcitonin rapid increase reported resulting rhabdomyolysis Risk factors SARS-CoV-2 SARS-CoV2 Shock Skeletal muscle Steroids therapy Treatment vaccination vaccine administration [DOI] 10.3389/fimmu.2022.845496 PMC 바로가기 [Article Type] Case Reports
Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy리툭시맙 기반 화학요법을 받고 있는 만성 림프구성 백혈병 환자에서 장기간 또는 재발하는 COVID-19 관련 사이토카인 폭풍Case Reports Published on 2022-03-012022-09-12 Journal: Clinical immunology (Orlando, Fla.) [Category] MERS, 진단, [키워드] addition Administered Anakinra Chemotherapy Corticosteroids Course COVID-19 Cyclophosphamide Cytokine storm Cytokine storm (hyperinflammatory syndrome) diagnosed diagnosed with COVID-19 died discharge fatigue Fever hospital Hospitalization Hyperinflammatory Hypoxemia intravenously laboratory parameter leukemia male Methylprednisolone oxygen saturation Patient Prednisolone progressed receiving regimen resolved Respiratory failure rituximab severe hypoxemia Shortness of breath Significant the patient Tocilizumab Treatment vincristine [DOI] 10.1016/j.clim.2022.108936 PMC 바로가기 [Article Type] Case Reports
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccinationCase Reports Published on 2022-02-262022-10-29 Journal: Infection [Category] COVID-19, COVID19(2023년), MERS, SARS, 진단, [키워드] addition adverse effect Anakinra approval combination treatment coronavirus disease Corticosteroid COVID-19 COVID-19 vaccine Dexamethasone female ferritin Frequency full recovery HLH Hyperferritinemia hyperinflammation immunization Intravenous immunoglobulin Kineret Lymphadenopathy macrophage activation syndrome majority mechanism mRNA pandemic Patient patients died performed Probability receptor reported Result SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine treated Treatment Trial vaccination Vaccine Viral vector vaccine [DOI] 10.1007/s15010-022-01786-y PMC 바로가기 [Article Type] Case Reports
Immunotherapy of COVID-19: Inside and Beyond IL-6 SignallingReview Published on 2022-02-222023-07-08 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] Anakinra Baricitinib COVID-19 Cytokines IL-6 sarilumab therapy Tocilizumab [DOI] 10.3389/fimmu.2022.795315 PMC 바로가기 [Article Type] Review